Laconext 10mg Injection

Introduction

Laconext is a prescription medication that contains the active ingredient Lacosamide. It is available under the brand name Laconext. This medication is primarily used for the treatment of certain types of seizures in adults and children with epilepsy.

Uses

Laconext is prescribed to manage partial-onset seizures in patients with epilepsy. It can be used as an adjunctive therapy (in combination with other antiepileptic drugs) to control seizures that are not adequately controlled with other medications.

Dosage and Administration

Laconext should be administered under the supervision of a healthcare professional. The dosage and administration instructions may vary depending on the individual patient’s condition and response to treatment. It is typically given as an intravenous (IV) infusion over a specified period of time.

Mechanism of Action

The active ingredient in Laconext, Lacosamide, works by stabilizing the overactive electrical signals in the brain that can lead to seizures. It does this by selectively enhancing the slow inactivation of voltage-gated sodium channels, which helps to reduce the abnormal electrical activity in the brain.

Side Effects

Common side effects may include dizziness, headache, nausea, vomiting, and fatigue. These side effects are generally mild and temporary. However, if they persist or become bothersome, consult a healthcare professional.

Serious side effects are rare, but they can occur. These may include a severe allergic reaction, changes in mood or behavior, difficulty breathing, or fainting. If any of these serious side effects occur, immediate medical attention should be sought.

Drug Interactions

Laconext may interact with certain medications, including other antiepileptic drugs, that can affect its effectiveness or increase the risk of side effects. Inform your healthcare professional about all the medications, supplements, or herbal products you are taking before starting Laconext.

Precautions

Before using Laconext, inform your healthcare professional about any existing medical conditions or allergies you may have. They should also be made aware of all medications you are currently taking to ensure safe and effective use of this medication.

Laconext should be used with caution in patients with liver or kidney problems, as the dosage may need to be adjusted. Note that sudden withdrawal of Laconext may increase the risk of seizures, so the medication should be discontinued gradually under medical supervision.

Storage

Laconext should be stored in a cool, dry place away from direct sunlight. It should be kept out of the reach of children and pets. Do not freeze the medication.

Patient Tips

• Follow the instructions provided by your healthcare professional regarding the dosage and administration of Laconext.
• If you miss a dose, contact your healthcare professional for guidance on what to do.
• Be aware of any potential side effects and contact your healthcare professional if you experience any concerning symptoms.
• Inform your healthcare professional about all medications, supplements, or herbal products you are taking before starting Laconext.
• Keep track of your seizures and report any changes or concerns to your healthcare professional.
• Store Laconext properly, following the storage instructions provided.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• EPLAID 100mg film coated tablets (Health Professionals SmPC) Available at:
• Lacosamide oral/injection (Drugs.com) [Accessed 2 Jun. 2024] (online) Available at:
• lacosamide (RX) [Accessed 8 Jun. 2024] (online) Available at:
• Lacosamide Injection (MedlinePlus) [Accessed 13 Jun. 2024] (online) Available at:
• Li J, Sun M, Wang X. The adverse-effect profile of lacosamide. Expert Opin Drug Saf. 2020 Feb;19(2):131-138. doi: 10.1080/14740338.2020.1713089. Epub 2020 Jan 15. [Accessed 2 Jun. 2024] Available at: